1University Hospitals of Leicester NHS Trust, Leicester, United Kingdom [email protected]
2Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
Dr. Pavord reports receiving payment for travel to an American Thoracic Society meeting from Boehringer Ingelheim, lecture fees from GlaxoSmithKline, Aerocrine, and AstraZeneca, grant support for a study of mepolizumab for severe asthma from GlaxoSmithKline, and consulting fees from Novartis, GlaxoSmithKline, AstraZeneca, and Merck. Dr. Bush reports receiving payment for travel to an American Thoracic Society meeting from GlaxoSmithKline, Merck, and Altana, lecture fees from Merck, GlaxoSmithKline, and AstraZeneca, and grant support for a study of inhaled mannitol for cystic fibrosis from Pharmaxis.
No other potential conflict of interest relevant to this letter was reported.
